Learn more

NEXEL CO LTD

Overview
  • Total Patents
    31
  • GoodIP Patent Rank
    51,562
  • Filing trend
    ⇧ 83.0%
About

NEXEL CO LTD has a total of 31 patent applications. It increased the IP activity by 83.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are VISION 7 GMBH, LONDON SCHOOL OF HYGIENE & TRO and GENVEC INC.

Patent filings per year

Chart showing NEXEL CO LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Woo Donghun 13
#2 Han Choong Sung 12
#3 Han Choongseong 7
#4 Woo Dong Hun 7
#5 Cho Gun Sik 5
#6 Kim Jeong Seong 5
#7 Jeon Hye Ryeon 5
#8 An Geun Ho 5
#9 Dong Hun Woo 4
#10 Ryu Junglim 4

Latest patents

Publication Filing date Title
KR20200045984A Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof
KR20200045983A Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof
WO2020084344A2 Compositions and methods for treating or preventing fibrosis
WO2020256162A2 Method for differentiation from human pluripotent stem cell to glutamatergic neuron by using inhibitor of insulin-like growth factor receptor, and glutamatergic neuron established thereby
WO2020175719A1 Composition for predicting prognosis of severe alcoholic hepatitis, and use thereof
KR20200099218A Simple method for differentiating human pluripotent stem cells into highly proliferative vascular endothelial cells for hemophilia A treatment
KR20200094016A Methods for producing in vitro wilson's disease model using human pluripotent stem cell and in vitro wilson's disease model produced by thereof
KR20200046869A Recombinant protein for idiopathic pulmonary fibrosis treatment or prevention and composition for idiopathic pulmonary fibrosis treatment or prevention containing thereof
KR20200046618A Recombinant protein for myocardial infarction treatment or prevention and composition for myocardial infarction treatment or prevention containing thereof
KR20200046689A Recombinant protein for alzheimer's disease treatment or prevention and composition for alzheimer's disease treatment or prevention containing thereof
KR102060256B1 Methods for preparing in vitro cultured hepatocytes using er stress reliever and in vitro cultured hepatocytes prepared by thereof
US2018334486A1 Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same
KR101994035B1 Method for generating human pluripotent stem cells derived functional cardiomyocytes by cell differentiation with maturation
KR20180126236A Recombinant protein for treatment or prevention and compositon for treatment or prevention containing thereof
CN108524914A Utilize butter oil ball-epidermal growth factor 8(MFGE8)Liver regeneration and hepatopathy improve purposes
KR20180038227A Method for differentiation of hepatocyte derived from human stem cells and Hepatocyte
KR20170019883A Method for enhancing metabolizing activity of hepatocytes
KR20170019601A Method for differentiation of hepatocyte
KR20170013621A Composition for preventing or treating tissue fibrosis by using milk fat globule-EGF factor 8